3 253

Cited 0 times in

Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan

Authors
 Choon O. Kim  ;  Sung K. Cho  ;  Eun S. Oh  ;  Min S. Park  ;  Jae-Yong Chung 
Citation
 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, Vol.60(1) : 49-54, 2012 
Journal Title
 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 
ISSN
 0160-2446 
Issue Date
2012
MeSH
ATP Binding Cassette Transporter, Sub-Family G, Member 2 ; ATP-Binding Cassette Transporters/genetics* ; Adult ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/pharmacokinetics ; Area Under Curve ; Dose-Response Relationship, Drug ; Genotype ; Humans ; Imidazoles/administration & dosage ; Imidazoles/pharmacokinetics* ; Male ; Multidrug Resistance-Associated Proteins/genetics* ; Neoplasm Proteins/genetics* ; Olmesartan Medoxomil ; Organic Anion Transporters/genetics* ; Polymorphism, Single Nucleotide ; Republic of Korea ; Solute Carrier Organic Anion Transporter Family Member 1b1 ; Tetrazoles/administration & dosage ; Tetrazoles/pharmacokinetics* ; Young Adult
Keywords
olmesartan ; MRP2 ; OATP1B1 ; BCRP ; pharmacokinetics
Abstract
This study was designed to determine whether genetic polymorphisms of multidrug-resistant protein 2 (ABCC2), organic anion transporting polypeptide 1B1 (SLCO1B1), and breast cancer resistance protein (ABCG2) have an effect on olmesartan pharmacokinetics in Korean subjects. Sixty-eight healthy male volunteers who participated in previous pharmacokinetics studies of olmesartan medoxomil (single dose, 20 mg or 40 mg) were enrolled. All subjects were analyzed and grouped according to the genotypes of ABCC2, SLCO1B1, and ABCG2. The dose-normalized peak plasma concentration (C(max)) and area under the plasma concentration-time curve (AUCt) values were analyzed. The dose-normalized mean C(max) and AUC(t) in the ABCC2 -24CT genotype group were higher than those in the -24CC genotype group [C(max,dn): CT 26.1 ± 6.5 (ng/mL)/mg versus CC 22.1 ± 6.7 (ng/mL)/mg, P = 0.010, AUC(t,dn): CT 178.7 ± 45.6 (hr·ng(-1)·mL(-1))/mg versus CC 149.9 ± 39.8 (hr·ng(-1)·mL(-1))/mg, P = 0.010]. The difference in AUC(t,dn) between the ABCC2 -1549GG and -1549GA genotype groups was statistically significant [GG 149.0 ± 41.0 (hr·ng(-1)·mL(-1))/mg versus GA 174.1 ± 43.3 (hr·ng(-1)·mL(-1))/mg, P = 0.019]. No significant differences were observed for any other single nucleotide polymorphism in ABCC2, SLCO1B1, or ABCG2. The ABCC2 -24CC genotype group exhibited lower systemic exposure of olmesartan than the -24CT genotype group, whereas no significant differences were observed in the other transporter genotype groups.
Full Text
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00005344-201207000-00007&LSLINK=80&D=ovft
DOI
22494992
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers
Yonsei Authors
Kim, Choon Ok(김춘옥) ORCID logo https://orcid.org/0000-0002-2319-1108
Park, Min Soo(박민수) ORCID logo https://orcid.org/0000-0002-4395-9938
Chung, Jae Yong(정재용)
Cho, Sung Kweon(조성권)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/90655
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse